Neurodegeneration and inflammation—an interesting interplay in Parkinson's disease
C Marogianni, M Sokratous, E Dardiotis… - International journal of …, 2020 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disorder, caused by, so far, unknown
pathogenetic mechanisms. There is no doubt that pro-inflammatory immune-mediated …
pathogenetic mechanisms. There is no doubt that pro-inflammatory immune-mediated …
Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery
Parkinson's Disease (PD) is a highly prevalent neurodegenerative disease among older
adults. PD neuropathology is marked by the progressive loss of the dopaminergic neurons …
adults. PD neuropathology is marked by the progressive loss of the dopaminergic neurons …
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population
Y Zhao, L Qin, H Pan, Z Liu, L Jiang, Y He, Q Zeng… - Brain, 2020 - academic.oup.com
This study aimed to determine the mutational spectrum of familial Parkinson's disease and
sporadic early-onset Parkinson's disease (sEOPD) in a mainland Chinese population and …
sporadic early-onset Parkinson's disease (sEOPD) in a mainland Chinese population and …
Blinded RT‐QuIC analysis of α‐Synuclein biomarker in skin tissue from Parkinson's disease patients
Background An unmet clinical need in Parkinson's disease (PD) is to identify biomarkers for
diagnosis, preferably in peripherally accessible tissues such as skin. Immunohistochemical …
diagnosis, preferably in peripherally accessible tissues such as skin. Immunohistochemical …
Alpha-synuclein as a biomarker of Parkinson's disease: good, but not good enough
Parkinson's disease (PD) is the second most common neurodegenerative disorder of the
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …
Lipid and lipid raft alteration in aging and neurodegenerative diseases: a window for the development of new biomarkers
F Mesa-Herrera, L Taoro-González… - International journal of …, 2019 - mdpi.com
Lipids in the brain are major components playing structural functions as well as
physiological roles in nerve cells, such as neural communication, neurogenesis, synaptic …
physiological roles in nerve cells, such as neural communication, neurogenesis, synaptic …
Probiotics for Parkinson's disease
P Gazerani - International journal of molecular sciences, 2019 - mdpi.com
Parkinson's disease (PD) is a complex neurological disorder classically characterized by
impairments in motor system function associated with loss of dopaminergic neurons in the …
impairments in motor system function associated with loss of dopaminergic neurons in the …
[HTML][HTML] Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease
E Kip, LC Parr-Brownlie - Ageing Research Reviews, 2022 - Elsevier
Parkinson's disease (PD) is the second most common age-associated neurodegenerative
disorder and is characterised by progressive loss of dopamine neurons in the substantia …
disorder and is characterised by progressive loss of dopamine neurons in the substantia …
Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status
D Koníčková, K Menšíková, L Tučková, E Hényková… - Biomedicines, 2022 - mdpi.com
The understanding of neurodegenerative diseases, traditionally considered to be well-
defined entities with distinguishable clinical phenotypes, has undergone a major shift over …
defined entities with distinguishable clinical phenotypes, has undergone a major shift over …
Clinical and imaging markers of prodromal Parkinson's disease
E Hustad, JO Aasly - Frontiers in neurology, 2020 - frontiersin.org
The diagnosis of Parkinson's disease (PD) relies on the clinical effects of dopamine
deficiency, including bradykinesia, rigidity and tremor, usually manifesting asymmetrically …
deficiency, including bradykinesia, rigidity and tremor, usually manifesting asymmetrically …